ADM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ADM is not a strong buy right now for a Beginner with a long-term focus and $50,000-$100,000 to deploy. The stock has decent fundamental momentum and improving guidance, but the current setup is mixed: price is near resistance, insiders and Congress are net sellers, and Wall Street is split between bullish target raises and persistent Underweight/Equal Weight views. Because the investor is impatient and does not want to wait for a better entry, I would still not call this a clear buy today; a cautious hold is the better call.
ADM is in an uptrend based on bullish moving averages (SMA_5 > SMA_20 > SMA_200), which supports constructive medium-term momentum. MACD histogram is positive at 0.839, though it is contracting, suggesting upside momentum is still present but less forceful. RSI_6 at 71.109 is elevated and near overbought territory, so the stock is not especially attractive for an immediate aggressive entry. Price at 77.55 is above the pivot (75.051) and below R1 (80.048), meaning it is trading in the upper part of its recent range with resistance nearby.
ADM delivered Q1 2026 results with revenue up 1.56% YoY, net income up 1.02% YoY, EPS up 1.64% YoY, and gross margin improving to 5.96%. Management also raised full-year adjusted EPS guidance to $4.15-$4.70, supported by better biofuels profitability and soybean crushing. News flow is favorable around biofuel blending mandates and stronger oilseed processing economics. Analysts at UBS, Barclays, Jefferies, and JPMorgan have all raised price targets recently, which shows improving expectations even if ratings remain mixed.
Insiders are selling, and the selling amount has increased sharply over the last month. Congress trading data also shows 1 recent sale and no purchases, which is a negative sentiment signal. Wall Street is still split, with Morgan Stanley and JPMorgan maintaining Underweight despite higher targets. The stock is already near short-term resistance and RSI is elevated, so fresh upside may be limited in the near term.
Latest quarter: Q1 2026. ADM posted revenue of $20.49B, up 1.56% YoY, net income of $298M, up 1.02% YoY, EPS of 0.62, up 1.64% YoY, and gross margin of 5.96%, up 1.88% YoY. The quarterly financial trend is modestly positive, not explosive, but the raised full-year EPS guidance suggests improving second-half conditions.
Analyst sentiment is improving on price targets, with UBS raising target to $90 and keeping Buy, Barclays lifting to $85 and keeping Equal Weight, Jefferies at $77 with Hold, and JPMorgan and Morgan Stanley still Underweight though both raised targets. Overall, the Street sees better fundamentals ahead, but the rating mix shows the pros are not fully aligned. Bulls point to better biofuel and oilseed margins; bears focus on company-specific execution and limited upside versus peers.
